Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_91789
Proper Citation: Millipore Cat# AB5320, RRID:AB_91789
Target Antigen: NG2 Chondroitin Sulfate Proteoglycan
Host Organism: rabbit
Clonality: polyclonal
Comments:
Applications: IHC, WB
Consolidation on 2/2024: AB_11213678
We found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Anti-NG2 Chondroitin Sulfate Proteoglycan Antibody.
Other
The authors state: "Depending on secondary antibody, there was false positive Rab6A staining selectively in microglial cells (1–3 larger granula in many cells) present also in the controls (see Figure S8). Only with biotinylated horse anti-goat (followed by CY3-conjugated streptavidin) and donkey anti-mouse Alexa 647 was this non-specific, selective staining prevented. Virtually all non-astrocytic cells examined are negative for Rab6A: 99% of NG2 cells; 100% of microglia; and 98.3% of oligodendrocytes from cortex, 99.5% from corpus callosum, and 100% from hippocampus (Figure 5), and no Rab6A+ neurons were found (Figure S9)."
Source: Antibody Registry
dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.